Consensus statement on the use of systemic therapies in pancreatic ductal adenocarcinoma in Asia

Systemic therapies, primarily cytotoxic chemotherapies, are the mainstay treatment option for pancreatic ductal adenocarcinoma (PDAC) alongside surgery. Several guidelines exist for managing PDAC within Asia, but recommendations for systemic therapies can differ significantly. Consequently, geograph...

Full description

Bibliographic Details

Published in:	ESMO Gastrointestinal Oncology
Main Authors:	D.-Y. Oh, B. Shen, S. Satoi, J. Zhou, K.-P. Kim, S.P. Choo, S.M. Woo, S.L. Chan, L. Shen, M. Ikeda
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Subjects:	pancreatic cancer pancreatic ductal adenocarcinoma systemic therapies expert consensus Delphi method Asia
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949819825000275